Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	polyubiquitin modification-dependent protein binding	UBQLNL UBQLN2 UBQLN1 UBQLN4 TNFAIP3	3.80e-05	59	128	5	GO:0031593
GeneOntologyMolecularFunction	microfilament motor activity	MYH13 MYO7A MYO10 MYO15A	1.00e-04	38	128	4	GO:0000146
GeneOntologyMolecularFunction	calmodulin binding	MYH13 MYO7A MYO10 RYR1 PLCB3 MYO15A NOS1 CEP97	1.20e-04	230	128	8	GO:0005516
GeneOntologyMolecularFunction	histone H2AXS139 kinase activity	ATR ATM	1.22e-04	3	128	2	GO:0035979
GeneOntologyMolecularFunction	ubiquitin-like protein binding	AMFR SMARCAD1 USP16 UBXN11 SIMC1 TNFAIP3	1.77e-04	128	128	6	GO:0032182
GeneOntologyMolecularFunction	calcium ion binding	MYL1 PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 RYR1 CDH20 CELSR2 PCDHGB4 PLCB2 PLCB3 PCDHGC3 NOTCH2	3.23e-04	749	128	14	GO:0005509
GeneOntologyMolecularFunction	histone H2AX kinase activity	ATR ATM	4.03e-04	5	128	2	GO:0141003
GeneOntologyMolecularFunction	dATP binding	ST13 ST13P5	4.03e-04	5	128	2	GO:0032564
GeneOntologyMolecularFunction	adenyl deoxyribonucleotide binding	ST13 ST13P5	6.01e-04	6	128	2	GO:0032558
GeneOntologyMolecularFunction	ubiquitin binding	AMFR SMARCAD1 USP16 UBXN11 TNFAIP3	6.31e-04	107	128	5	GO:0043130
GeneOntologyMolecularFunction	histone modifying activity	BRPF3 ATR FBL ASH1L USP16 JMJD1C ATM	6.95e-04	229	128	7	GO:0140993
GeneOntologyMolecularFunction	purine deoxyribonucleotide binding	ST13 ST13P5	8.38e-04	7	128	2	GO:0032554
GeneOntologyMolecularFunction	molecular adaptor activity	AMFR MAK UBQLN2 RIPK3 GAS2L3 RB1 DVL2 USP16 JMJD1C ST13 TOMM70 ZMYND10 BRDT TRIM55 PLCB3 CNOT1 MAML3 MED12 ZNF541	1.03e-03	1356	128	19	GO:0060090
GeneOntologyMolecularFunction	deoxyribonucleotide binding	ST13 ST13P5	1.43e-03	9	128	2	GO:0032552
GeneOntologyMolecularFunction	aryl hydrocarbon receptor binding	AHR TAF4	1.43e-03	9	128	2	GO:0017162
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	RB1 JMJD1C STAT1 AHR TAF4 CNOT1 MED12 NR1H4 NOTCH2	1.48e-03	417	128	9	GO:0061629
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PTPN23 CDH20 CELSR2 PCDHGB4 PCDHGC3	2.29e-07	187	126	10	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PTPN23 CDH20 CELSR2 PCDHGB4 TNFAIP3 PCDHGC3	3.56e-06	313	126	11	GO:0098742
GeneOntologyBiologicalProcess	regulation of organelle assembly	MAK UBQLN2 EVI5 RAB3GAP1 CCDC88A ZMYND10 ATM CNOT1 CEP97 HTT	8.74e-06	280	126	10	GO:1902115
GeneOntologyBiologicalProcess	positive regulation of motile cilium assembly	ZMYND10 HTT	3.70e-05	2	126	2	GO:1905505
GeneOntologyBiologicalProcess	regulation of motile cilium assembly	ZMYND10 HTT	3.70e-05	2	126	2	GO:1905503
GeneOntologyBiologicalProcess	telomerase catalytic core complex assembly	ATR ATM	3.70e-05	2	126	2	GO:1904868
GeneOntologyBiologicalProcess	positive regulation of telomerase catalytic core complex assembly	ATR ATM	3.70e-05	2	126	2	GO:1904884
GeneOntologyBiologicalProcess	regulation of telomerase catalytic core complex assembly	ATR ATM	3.70e-05	2	126	2	GO:1904882
GeneOntologyBiologicalProcess	regulation of cilium assembly	MAK EVI5 CCDC88A ZMYND10 CEP97 HTT	5.30e-05	108	126	6	GO:1902017
GeneOntologyBiologicalProcess	organelle assembly	MAK UBQLN2 UBQLN1 MYO7A TUBB PTPN23 RO60 EVI5 RAB3GAP1 CCDC88A CELSR2 ZMYND10 CEP89 CC2D2A ATM CNOT1 CEP97 GOLGA2 HTT	6.12e-05	1138	126	19	GO:0070925
GeneOntologyBiologicalProcess	cilium assembly	MAK PTPN23 RO60 EVI5 CCDC88A CELSR2 ZMYND10 CEP89 CC2D2A CEP97 HTT	8.96e-05	444	126	11	GO:0060271
GeneOntologyBiologicalProcess	synaptic target recognition	PLXND1 SEMA3A	1.11e-04	3	126	2	GO:0008039
GeneOntologyBiologicalProcess	establishment of RNA localization to telomere	ATR ATM	1.11e-04	3	126	2	GO:0097694
GeneOntologyBiologicalProcess	establishment of protein-containing complex localization to telomere	ATR ATM	1.11e-04	3	126	2	GO:0097695
GeneOntologyBiologicalProcess	cilium organization	MAK PTPN23 RO60 EVI5 CCDC88A CELSR2 ZMYND10 CEP89 CC2D2A CEP97 HTT	1.65e-04	476	126	11	GO:0044782
GeneOntologyBiologicalProcess	mature B cell differentiation	DPP4 LGALS8 TNFAIP3 NOTCH2	1.93e-04	47	126	4	GO:0002335
GeneOntologyBiologicalProcess	negative regulation of toll-like receptor 3 signaling pathway	UBQLN1 TNFAIP3	2.20e-04	4	126	2	GO:0034140
GeneOntologyCellularComponent	myosin complex	MYL1 MYH13 MYO7A MYO10 MYO15A	2.94e-05	59	127	5	GO:0016459
GeneOntologyCellularComponent	ISGF3 complex	STAT1 STAT2	1.09e-04	3	127	2	GO:0070721
Domain	STI1	UBQLN2 UBQLN1 UBQLN4 ST13 ST13P5	3.29e-09	10	127	5	SM00727
Domain	STI1_HS-bd	UBQLN2 UBQLN1 UBQLN4 ST13 ST13P5	3.29e-09	10	127	5	IPR006636
Domain	Cadherin_tail	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB4 PCDHGC3	4.94e-09	37	127	7	PF15974
Domain	Cadherin_CBD	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB4 PCDHGC3	4.94e-09	37	127	7	IPR031904
Domain	Ubiquilin	UBQLNL UBQLN2 UBQLN1 UBQLN4	3.03e-08	6	127	4	IPR015496
Domain	Cadherin_CS	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 CDH20 CELSR2 PCDHGB4 PCDHGC3	5.62e-08	109	127	9	IPR020894
Domain	CADHERIN_1	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 CDH20 CELSR2 PCDHGB4 PCDHGC3	7.69e-08	113	127	9	PS00232
Domain	Cadherin	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 CDH20 CELSR2 PCDHGB4 PCDHGC3	7.69e-08	113	127	9	PF00028
Domain	CADHERIN_2	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 CDH20 CELSR2 PCDHGB4 PCDHGC3	8.30e-08	114	127	9	PS50268
Domain	-	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 CDH20 CELSR2 PCDHGB4 PCDHGC3	8.30e-08	114	127	9	2.60.40.60
Domain	CA	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 CDH20 CELSR2 PCDHGB4 PCDHGC3	8.95e-08	115	127	9	SM00112
Domain	Cadherin-like	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 CDH20 CELSR2 PCDHGB4 PCDHGC3	9.65e-08	116	127	9	IPR015919
Domain	Cadherin	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 CDH20 CELSR2 PCDHGB4 PCDHGC3	1.12e-07	118	127	9	IPR002126
Domain	Cadherin_2	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB4 PCDHGC3	2.86e-07	65	127	7	PF08266
Domain	Cadherin_N	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB4 PCDHGC3	2.86e-07	65	127	7	IPR013164
Domain	Cadherin_C	PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB4 PCDHGC3	3.77e-07	42	127	6	IPR032455
Domain	Cadherin_C_2	PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB4 PCDHGC3	3.77e-07	42	127	6	PF16492
Domain	MYTH4	MYO7A MYO10 MYO15A	2.50e-05	9	127	3	PS51016
Domain	MyTH4	MYO7A MYO10 MYO15A	2.50e-05	9	127	3	SM00139
Domain	MyTH4_dom	MYO7A MYO10 MYO15A	2.50e-05	9	127	3	IPR000857
Domain	MyTH4	MYO7A MYO10 MYO15A	2.50e-05	9	127	3	PF00784
Domain	Gonadal	DGCR6 DGCR6L	4.59e-05	2	127	2	IPR010849
Domain	DGCR6	DGCR6 DGCR6L	4.59e-05	2	127	2	PF07324
Domain	Ubiquilin-1/2	UBQLN2 UBQLN1	4.59e-05	2	127	2	IPR028430
Domain	ARM-type_fold	DOCK2 UBQLN2 UBQLN1 ATR MROH5 NBEA ARMCX1 RANBP17 ATM HTT	1.09e-04	339	127	10	IPR016024
Domain	IQ	MYH13 MYO7A MYO10 MYO15A CEP97	1.22e-04	71	127	5	PF00612
Domain	Myosin_head_motor_dom	MYH13 MYO7A MYO10 MYO15A	1.26e-04	38	127	4	IPR001609
Domain	MYOSIN_MOTOR	MYH13 MYO7A MYO10 MYO15A	1.26e-04	38	127	4	PS51456
Domain	Myosin_head	MYH13 MYO7A MYO10 MYO15A	1.26e-04	38	127	4	PF00063
Domain	MYSc	MYH13 MYO7A MYO10 MYO15A	1.26e-04	38	127	4	SM00242
Domain	PLC-beta_C	PLCB2 PLCB3	1.37e-04	3	127	2	PF08703
Domain	PLC-beta_C	PLCB2 PLCB3	1.37e-04	3	127	2	IPR014815
Domain	UBQ	UBQLNL UBQLN2 UBQLN1 UBQLN4	2.05e-04	43	127	4	SM00213
Domain	IQ	MYH13 MYO7A MYO10 MYO15A CEP97	2.28e-04	81	127	5	SM00015
Domain	Ubiquitin-rel_dom	UBQLNL UBQLN2 UBQLN1 MYO7A UBQLN4 DVL2 UBXN11	2.66e-04	184	127	7	IPR029071
Domain	PLC-beta	PLCB2 PLCB3	2.73e-04	4	127	2	IPR016280
Domain	6-PGluconate_DH_C-like	UBQLN2 UBQLN1 UBQLN4	2.75e-04	19	127	3	IPR008927
Domain	ubiquitin	UBQLNL UBQLN2 UBQLN1 UBQLN4	2.90e-04	47	127	4	PF00240
Domain	IQ_motif_EF-hand-BS	MYH13 MYO7A MYO10 MYO15A CEP97	3.72e-04	90	127	5	IPR000048
Domain	IQ	MYH13 MYO7A MYO10 MYO15A CEP97	4.33e-04	93	127	5	PS50096
Domain	FATC	ATR ATM	4.53e-04	5	127	2	PF02260
Domain	UBIQUITIN_2	UBQLNL UBQLN2 UBQLN1 UBQLN4	4.96e-04	54	127	4	PS50053
Domain	ARM-like	DOCK2 ATR MROH5 NBEA ARMCX1 RANBP17 MED12 HTT	5.23e-04	270	127	8	IPR011989
Domain	Ubiquitin_dom	UBQLNL UBQLN2 UBQLN1 UBQLN4	6.51e-04	58	127	4	IPR000626
Domain	FAT	ATR ATM	6.76e-04	6	127	2	PS51189
Domain	FATC	ATR ATM	6.76e-04	6	127	2	PS51190
Domain	FAT	ATR ATM	6.76e-04	6	127	2	PF02259
Domain	PIK-rel_kinase_FAT	ATR ATM	6.76e-04	6	127	2	IPR003151
Domain	FATC_dom	ATR ATM	6.76e-04	6	127	2	IPR003152
Domain	PIK_FAT	ATR ATM	6.76e-04	6	127	2	IPR014009
Domain	FATC	ATR ATM	6.76e-04	6	127	2	SM01343
Domain	IPT	PLXND1 PKHD1L1 NFATC4	7.97e-04	27	127	3	SM00429
Domain	HRM	ADGRB3 CELSR2 ADGRA3	8.88e-04	28	127	3	PF02793
Domain	STAT_TF_DNA-bd_sub	STAT1 STAT2	9.42e-04	7	127	2	IPR012345
Domain	STAT	STAT1 STAT2	9.42e-04	7	127	2	IPR001217
Domain	Pept_M16_Zn_BS	NRDC PITRM1	9.42e-04	7	127	2	IPR001431
Domain	Pept_M16_dom	NRDC PITRM1	9.42e-04	7	127	2	IPR011237
Domain	Metalloenz_LuxS/M16	NRDC PITRM1	9.42e-04	7	127	2	IPR011249
Domain	STAT_int	STAT1 STAT2	9.42e-04	7	127	2	SM00964
Domain	Peptidase_M16	NRDC PITRM1	9.42e-04	7	127	2	PF00675
Domain	STAT_TF_DNA-bd	STAT1 STAT2	9.42e-04	7	127	2	IPR013801
Domain	STAT_bind	STAT1 STAT2	9.42e-04	7	127	2	PF02864
Domain	STAT_int	STAT1 STAT2	9.42e-04	7	127	2	PF02865
Domain	-	STAT1 STAT2	9.42e-04	7	127	2	1.10.532.10
Domain	STAT_alpha	STAT1 STAT2	9.42e-04	7	127	2	PF01017
Domain	Peptidase_M16_C	NRDC PITRM1	9.42e-04	7	127	2	IPR007863
Domain	-	STAT1 STAT2	9.42e-04	7	127	2	1.20.1050.20
Domain	STAT_TF_prot_interaction	STAT1 STAT2	9.42e-04	7	127	2	IPR013799
Domain	STAT_TF_coiled-coil	STAT1 STAT2	9.42e-04	7	127	2	IPR015988
Domain	-	STAT1 STAT2	9.42e-04	7	127	2	2.60.40.630
Domain	Peptidase_M16_C	NRDC PITRM1	9.42e-04	7	127	2	PF05193
Domain	Pept_M16_N	NRDC PITRM1	9.42e-04	7	127	2	IPR011765
Domain	-	NRDC PITRM1	9.42e-04	7	127	2	3.30.830.10
Domain	INSULINASE	NRDC PITRM1	9.42e-04	7	127	2	PS00143
Domain	UBA-like	UBQLN2 UBQLN1 UBQLN4 SMARCAD1	9.45e-04	64	127	4	IPR009060
Domain	UBA	UBQLN2 UBQLN1 UBQLN4	1.09e-03	30	127	3	SM00165
Domain	TIG	PLXND1 PKHD1L1 NFATC4	1.20e-03	31	127	3	PF01833
Domain	STAT_TF_alpha	STAT1 STAT2	1.25e-03	8	127	2	IPR013800
Domain	IPT	PLXND1 PKHD1L1 NFATC4	1.32e-03	32	127	3	IPR002909
Domain	GPS	ADGRB3 CELSR2 ADGRA3	1.58e-03	34	127	3	SM00303
Domain	GPS	ADGRB3 CELSR2 ADGRA3	1.71e-03	35	127	3	PF01825
Domain	UBA	UBQLN2 UBQLN1 UBQLN4	1.86e-03	36	127	3	PF00627
Domain	GPS	ADGRB3 CELSR2 ADGRA3	1.86e-03	36	127	3	PS50221
Domain	CUE	AMFR SMARCAD1	1.99e-03	10	127	2	IPR003892
Domain	CUE	AMFR SMARCAD1	1.99e-03	10	127	2	PS51140
Domain	UBIQUITIN_1	UBQLN2 UBQLN1 UBQLN4	2.02e-03	37	127	3	PS00299
Domain	GPS	ADGRB3 CELSR2 ADGRA3	2.02e-03	37	127	3	IPR000203
Domain	BROMODOMAIN_1	BRPF3 ASH1L BRDT	2.02e-03	37	127	3	PS00633
Domain	Bromodomain	BRPF3 ASH1L BRDT	2.18e-03	38	127	3	PF00439
Domain	GAIN_dom_N	ADGRB3 CELSR2	2.42e-03	11	127	2	IPR032471
Domain	GAIN	ADGRB3 CELSR2	2.42e-03	11	127	2	PF16489
Domain	GPCR_2_extracellular_dom	ADGRB3 CELSR2 ADGRA3	2.52e-03	40	127	3	IPR001879
Domain	G_PROTEIN_RECEP_F2_1	ADGRB3 CELSR2 ADGRA3	2.52e-03	40	127	3	PS00649
Domain	G_PROTEIN_RECEP_F2_3	ADGRB3 CELSR2 ADGRA3	2.52e-03	40	127	3	PS50227
Domain	BROMODOMAIN_2	BRPF3 ASH1L BRDT	2.71e-03	41	127	3	PS50014
Domain	Bromodomain	BRPF3 ASH1L BRDT	2.90e-03	42	127	3	IPR001487
Domain	BROMO	BRPF3 ASH1L BRDT	2.90e-03	42	127	3	SM00297
Domain	-	BRPF3 ASH1L BRDT	2.90e-03	42	127	3	1.20.920.10
Domain	UBA	UBQLN2 UBQLN1 UBQLN4	3.32e-03	44	127	3	IPR015940
Domain	FERM_M	MYO7A MYO10 MYO15A	3.77e-03	46	127	3	PF00373
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 CELSR2 PCDHGB4 PCDHGC3	2.82e-10	72	129	8	10380929
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 CELSR2 PCDHGB4 PCDHGC3	4.88e-10	77	129	8	10835267
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 CELSR2 PCDHGB4 PCDHGC3	6.66e-10	80	129	8	10716726
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	KIFBP UBQLN2 UBQLN1 NRDC TCEAL4 SEC24A TUBB DVL2 NAP1L1 PTPN23 RO60 SMARCAD1 CTSA ST13 ZYX LAP3 STAT1 RAB3GAP1 AKAP10 PLCB3 SNRPA CNOT1 HTT	3.97e-09	1455	129	23	22863883
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB4 PCDHGC3	6.58e-09	68	129	7	11230163
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB4 PCDHGC3	1.20e-08	74	129	7	10817752
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	MYO10 FBL SEC24A DVL2 NAP1L1 MSH5 ZYX STAT1 STAT2 MAP3K3 CCDC88A AHR SNRPA CNOT1 CEP97 MED12 GOLGA2 SAMD4A	5.96e-08	1038	129	18	26673895
Pubmed	Herp enhances ER-associated protein degradation by recruiting ubiquilins.	UBQLN2 UBQLN1 UBQLN4	1.99e-07	4	129	3	18307982
Pubmed	Maturation of postnatally generated olfactory bulb granule cells depends on functional γ-protocadherin expression.	PCDHGC5 PCDHGB5 PCDHGB4 PCDHGC3	2.39e-07	15	129	4	23515096
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	ATP6AP1 UBQLN1 GALNT1 ATR PITRM1 TCEAL4 PLXND1 TOMM70 CELSR2 AHR SGCE ATM TAF4 ATP12A PCDHGC3 NOTCH2 ADGRA3	4.33e-07	1061	129	17	33845483
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	STARD13 KIFBP MAK PITRM1 RB1 MYO7A IFFO1 SNX33 MAGT1 CTSA ZYX MAP3K3 ARID3B CCDC88A ZMYND10 AMOT MUC5AC CNOT1 CEP97	4.42e-07	1321	129	19	27173435
Pubmed	RTL8 promotes nuclear localization of UBQLN2 to subnuclear compartments associated with protein quality control.	UBQLN2 UBQLN1 UBQLN4	9.89e-07	6	129	3	35247097
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	FBL NAP1L1 PTPN23 JMJD1C ZYX STAT1 ARID3B AMOT TAF4 CNOT1 MED12 HTT	1.04e-06	549	129	12	38280479
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DGCR6 UBQLN2 UBQLN1 FOLH1 UBQLN4 ASH1L TUBB NAP1L1 ADGRB3 CHD9 NBEA SMARCAD1 USP16 ST13 STAT1 ZNF197 FMN2 ATM	1.33e-06	1285	129	18	35914814
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	KIFBP ATR NRDC PITRM1 FBL U2SURP NAP1L1 RO60 SMARCAD1 ST13 LAP3 STAT1 TOMM70 AMOT CC2D2A ATM SNRPA CNOT1 ADGRA3	1.37e-06	1425	129	19	30948266
Pubmed	VCP phosphorylation-dependent interaction partners prevent apoptosis in Helicobacter pylori-infected gastric epithelial cells.	AMFR KIFBP UBQLN1 PTPN23 NBEA ST13 STAT1 RAB3GAP1 HTT	1.39e-06	288	129	9	23383273
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	MYL1 ATP6AP1 UBQLN2 UBQLN1 NRDC U2SURP TUBB PTPN23 SMARCAD1 MAGT1 CTSA ZYX STAT1 TNFAIP3 SNRPA ST13P5 CNOT1 NOTCH2	1.52e-06	1297	129	18	33545068
Pubmed	Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions.	UBQLN2 UBQLN1 HTT	1.73e-06	7	129	3	23774650
Pubmed	Differential expression of individual gamma-protocadherins during mouse brain development.	PCDHGC5 PCDHGB4 PCDHGC3	1.73e-06	7	129	3	15964765
Pubmed	Tails of unconventional myosins.	MYO7A MYO10 MYO15A	1.73e-06	7	129	3	11212352
Pubmed	Structure of hRpn10 Bound to UBQLN2 UBL Illustrates Basis for Complementarity between Shuttle Factors and Substrates at the Proteasome.	UBQLN2 UBQLN1 UBQLN4	1.73e-06	7	129	3	30664872
Pubmed	Functional proteomics mapping of a human signaling pathway.	STARD13 UBQLN2 UBQLN1 UBQLN4 ASH1L LAMA4 ST13 ZYX UBXN11 TNFAIP3 SNRPA NOTCH2	2.23e-06	591	129	12	15231748
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	MYH13 MYO7A U2SURP CHD9 NBEA MAGT1 ATM TAF4 CNOT1 MED12 GOLGA2	2.66e-06	497	129	11	36774506
Pubmed	Ubiquilin4 is an adaptor protein that recruits Ubiquilin1 to the autophagy machinery.	UBQLN2 UBQLN1 UBQLN4	2.75e-06	8	129	3	23459205
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHGC5 PCDHGB5 PCDHGB4 PCDHGC3	3.45e-06	28	129	4	15347688
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	UBQLNL RB1 PCDHGB3 MYO7A NBEA RYR1 CDH20 AMOT AHR FMN2 PLCB3 ATM CNOT1	3.81e-06	736	129	13	29676528
Pubmed	Combinatorial CRISPR screen identifies fitness effects of gene paralogues.	ATR NRDC RB1 SEC24A RANBP17 SNRPA HTT	6.45e-06	186	129	7	33637726
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	TUBB NAP1L1 PPWD1 JMJD1C ZYX STAT1 ARID3B SIMC1 TAF4 CEP97	6.61e-06	444	129	10	34795231
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	SEC24A DVL2 NAP1L1 JMJD1C CCDC88A AMOT CNOT1 GOLGA2	6.66e-06	263	129	8	34702444
Pubmed	Wnt signalling regulates paxillin ubiquitination essential for mesodermal cell motility.	UBQLN2 UBQLN1 UBQLN4 TOMM70	6.80e-06	33	129	4	17558393
Pubmed	Functional significance of isoform diversification in the protocadherin gamma gene cluster.	PCDHGC5 PCDHGB5 PCDHGB4 PCDHGC3	7.68e-06	34	129	4	22884324
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	ATP6AP1 GALNT1 ATR LAMA4 PLXND1 MAGT1 CTSA SEMA3A CELSR2 P3H2 SGCE ATM GOLGA2 NOTCH2 ADGRA3 HTT	1.01e-05	1201	129	16	35696571
Pubmed	A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.	MYL1 RB1 IFFO1 U2SURP TUBB ZYX SNRPA CNOT1	1.16e-05	284	129	8	29459677
Pubmed	Single-stranded DNA orchestrates an ATM-to-ATR switch at DNA breaks.	ATR ATM	1.37e-05	2	129	2	19285939
Pubmed	Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation.	STAT1 STAT2	1.37e-05	2	129	2	12388709
Pubmed	Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages.	STAT1 NR1H4	1.37e-05	2	129	2	19393742
Pubmed	Expression variations of DNA damage response genes ATM and ATR in blood cancer patients.	ATR ATM	1.37e-05	2	129	2	37338595
Pubmed	DNA damage induces a kinetochore-based ATM/ATR-independent SAC arrest unique to the first meiotic division in mouse oocytes.	ATR ATM	1.37e-05	2	129	2	28851706
Pubmed	Investigation of MYO15A and MYO7A Mutations in Iranian Patients with Nonsyndromic Hearing Loss.	MYO7A MYO15A	1.37e-05	2	129	2	31997689
Pubmed	Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease.	ATM HTT	1.37e-05	2	129	2	25540325
Pubmed	Novel insights into the mechanism of cell cycle kinases Mec1(ATR) and Tel1(ATM).	ATR ATM	1.37e-05	2	129	2	34151669
Pubmed	Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha.	STAT1 STAT2	1.37e-05	2	129	2	8621447
Pubmed	Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2.	STAT1 STAT2	1.37e-05	2	129	2	16501077
Pubmed	Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction.	STAT1 STAT2	1.37e-05	2	129	2	11932384
Pubmed	Inhibition of Atm and/or Atr disrupts gene silencing on the inactive X chromosome.	ATR ATM	1.37e-05	2	129	2	16213462
Pubmed	ATR- and ATM-Mediated DNA Damage Response Is Dependent on Excision Repair Assembly during G1 but Not in S Phase of Cell Cycle.	ATR ATM	1.37e-05	2	129	2	27442013
Pubmed	Induction of ATM/ATR pathway combined with Vγ2Vδ2 T cells enhances cytotoxicity of ovarian cancer cells.	ATR ATM	1.37e-05	2	129	2	24726882
Pubmed	rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis.	ATR ATM	1.37e-05	2	129	2	26061708
Pubmed	A Mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosis.	STAT1 STAT2	1.37e-05	2	129	2	17442890
Pubmed	Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells.	STAT1 AHR	1.37e-05	2	129	2	18607004
Pubmed	A new Drosophila model of Ubiquilin knockdown shows the effect of impaired proteostasis on locomotive and learning abilities.	UBQLN2 UBQLN1	1.37e-05	2	129	2	29247619
Pubmed	Functional significance for a heterogenous ribonucleoprotein A18 signature RNA motif in the 3'-untranslated region of ataxia telangiectasia mutated and Rad3-related (ATR) transcript.	ATR ATM	1.37e-05	2	129	2	20103595
Pubmed	Towards a molecular understanding of the overlapping and distinct roles of UBQLN1 and UBQLN2 in lung cancer progression and metastasis.	UBQLN2 UBQLN1	1.37e-05	2	129	2	35063704
Pubmed	An Electrical Impedance-Based Method for Quantitative Real-Time Analysis of Semaphorin-Elicited Endothelial Cell Collapse.	PLXND1 SEMA3A	1.37e-05	2	129	2	27787852
Pubmed	Cooperative Transcriptional Activation of Antimicrobial Genes by STAT and NF-κB Pathways by Concerted Recruitment of the Mediator Complex.	STAT1 STAT2	1.37e-05	2	129	2	26146080
Pubmed	Interplay between ATM and ATR in the regulation of common fragile site stability.	ATR ATM	1.37e-05	2	129	2	17934520
Pubmed	Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest.	RB1 AHR	1.37e-05	2	129	2	10644764
Pubmed	Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.	ATR ATM	1.37e-05	2	129	2	25483091
Pubmed	ATM and ATR activities maintain replication fork integrity during SV40 chromatin replication.	ATR ATM	1.37e-05	2	129	2	23592994
Pubmed	Bleomycin-induced over-replication involves sustained inhibition of mitotic entry through the ATM/ATR pathway.	ATR ATM	1.37e-05	2	129	2	19527713
Pubmed	Cytokine-mediated inflammation, tumorigenesis, and disease-associated JAK/STAT/SOCS signaling circuits in the CNS.	STAT1 STAT2	1.37e-05	2	129	2	15850655
Pubmed	Structural analysis of the STAT1:STAT2 heterodimer revealed the mechanism of Sendai virus C protein-mediated blockade of type 1 interferon signaling.	STAT1 STAT2	1.37e-05	2	129	2	28978648
Pubmed	Identification of amino-acid residues in the V protein of peste des petits ruminants essential for interference and suppression of STAT-mediated interferon signaling.	STAT1 STAT2	1.37e-05	2	129	2	25965795
Pubmed	Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex.	ATM HTT	1.37e-05	2	129	2	28017939
Pubmed	Variable phenotype of del45-55 Becker patients correlated with nNOSμ mislocalization and RYR1 hypernitrosylation.	RYR1 NOS1	1.37e-05	2	129	2	22589245
Pubmed	ATM and ATR signaling at a glance.	ATR ATM	1.37e-05	2	129	2	26567218
Pubmed	2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds.	UBQLN1 NAP1L1	1.37e-05	2	129	2	22134777
Pubmed	Hepatitis C virus expression suppresses interferon signaling by degrading STAT1.	STAT1 STAT2	1.37e-05	2	129	2	15825084
Pubmed	STAT2 hypomorphic mutant mice display impaired dendritic cell development and antiviral response.	STAT1 STAT2	1.37e-05	2	129	2	19272190
Pubmed	A mouse gene (Dgcr6) related to the Drosophila gonadal gene is expressed in early embryogenesis and is the homolog of a human gene deleted in DiGeorge syndrome.	DGCR6 DGCR6L	1.37e-05	2	129	2	9605865
Pubmed	Cancer genome datamining and functional genetic analysis implicate mechanisms of ATM/ATR dysfunction underpinning carcinogenesis.	ATR ATM	1.37e-05	2	129	2	33742106
Pubmed	Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory.	RB1 ATM	1.37e-05	2	129	2	25159481
Pubmed	Roles of ATM and ATR in DNA double strand breaks and replication stress.	ATR ATM	1.37e-05	2	129	2	33887296
Pubmed	ATR disruption leads to chromosomal fragmentation and early embryonic lethality.	ATR ATM	1.37e-05	2	129	2	10691732
Pubmed	Mutations of the Huntington's disease protein impact on the ATM-dependent signaling and repair pathways of the radiation-induced DNA double-strand breaks: corrective effect of statins and bisphosphonates.	ATM HTT	1.37e-05	2	129	2	24277524
Pubmed	Hypoosmotic stress induces R loop formation in nucleoli and ATR/ATM-dependent silencing of nucleolar transcription.	ATR ATM	1.37e-05	2	129	2	31114877
Pubmed	STAT2-dependent restriction of Zika virus by human macrophages but not dendritic cells.	STAT1 STAT2	1.37e-05	2	129	2	33979266
Pubmed	Shift in G1-Checkpoint from ATM-Alone to a Cooperative ATM Plus ATR Regulation with Increasing Dose of Radiation.	ATR ATM	1.37e-05	2	129	2	35011623
Pubmed	Interaction of mumps virus V protein variants with STAT1-STAT2 heterodimer: experimental and theoretical studies.	STAT1 STAT2	1.37e-05	2	129	2	20937132
Pubmed	The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.	ATR ATM	1.37e-05	2	129	2	26517239
Pubmed	St13 protects against disordered acinar cell arachidonic acid pathway in chronic pancreatitis.	ST13 ST13P5	1.37e-05	2	129	2	35562743
Pubmed	Arylhydrocarbon receptor (AhR) activation in airway epithelial cells induces MUC5AC via reactive oxygen species (ROS) production.	AHR MUC5AC	1.37e-05	2	129	2	20709182
Pubmed	DNA damage-sensing kinases mediate the mouse 2-cell embryo's response to genotoxic stress.	ATR ATM	1.37e-05	2	129	2	21593482
Pubmed	A synthetic lethal screen reveals enhanced sensitivity to ATR inhibitor treatment in mantle cell lymphoma with ATM loss-of-function.	ATR ATM	1.37e-05	2	129	2	25232030
Pubmed	Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells.	STAT1 STAT2	1.37e-05	2	129	2	10446176
Pubmed	ATM acts downstream of ATR in the DNA damage response signaling of bystander cells.	ATR ATM	1.37e-05	2	129	2	18757420
Pubmed	Cellular responses to the DNA strand-scission enediyne C-1027 can be independent of ATM, ATR, and DNA-PK kinases.	ATR ATM	1.37e-05	2	129	2	11927575
Pubmed	In Vivo and In Vitro Effects of ATM/ATR Signaling Pathway on Proliferation, Apoptosis, and Radiosensitivity of Nasopharyngeal Carcinoma Cells.	ATR ATM	1.37e-05	2	129	2	28820634
Pubmed	ATM and ATR play complementary roles in the behavior of excitatory and inhibitory vesicle populations.	ATR ATM	1.37e-05	2	129	2	29279380
Pubmed	ATR regulates fragile site stability.	ATR ATM	1.37e-05	2	129	2	12526805
Pubmed	Dysregulation of DGCR6 and DGCR6L: psychopathological outcomes in chromosome 22q11.2 deletion syndrome.	DGCR6 DGCR6L	1.37e-05	2	129	2	22832905
Pubmed	Investigation of switch from ATM to ATR signaling at the sites of DNA damage induced by low and high LET radiation.	ATR ATM	1.37e-05	2	129	2	24238855
Pubmed	Recruitment of ATR to sites of ionising radiation-induced DNA damage requires ATM and components of the MRN protein complex.	ATR ATM	1.37e-05	2	129	2	16474843
Pubmed	The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes.	ATR ATM	1.37e-05	2	129	2	8843195
Pubmed	Viral DNA replication-dependent DNA damage response activation during BK polyomavirus infection.	ATR ATM	1.37e-05	2	129	2	25694603
Pubmed	Deletion of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells.	STAT1 STAT2	1.37e-05	2	129	2	21795355
Pubmed	The genomic structure of the STAT genes: multiple exons in coincident sites in Stat1 and Stat2.	STAT1 STAT2	1.37e-05	2	129	2	7885841
Pubmed	Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance.	ATR ATM	1.37e-05	2	129	2	26124337
Pubmed	Resveratrol analogue (E)-8-acetoxy-2-[2-(3,4-diacetoxyphenyl)ethenyl]-quinazoline induces G₂/M cell cycle arrest through the activation of ATM/ATR in human cervical carcinoma HeLa cells.	ATR ATM	1.37e-05	2	129	2	25812484
Pubmed	Roles of ATM and ATR-mediated DNA damage responses during lytic BK polyomavirus infection.	ATR ATM	1.37e-05	2	129	2	22952448
Interaction	PCDHGB3 interactions	PCDHGB5 PCDHGB3 PCDHGB4 PCDHGC3	1.07e-07	8	128	4	int:PCDHGB3
Interaction	LATS1 interactions	MYL1 UBQLN2 MYH13 FBL U2SURP TUBB DVL2 ARMCX1 ZYX MAP3K3 CCDC88A AMOT TAF4 GOLGA2 NOTCH2	1.34e-07	440	128	15	int:LATS1
Interaction	NPY interactions	DPP4 UBQLN2 UBQLN1 ATP12A	4.43e-06	18	128	4	int:NPY
Interaction	PCDHGB2 interactions	PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB4 PCDHGC3	8.51e-06	44	128	5	int:PCDHGB2
Interaction	H2BC5 interactions	UBQLN2 PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 U2SURP TOMM70 PCDHGB4 TAF4 PCDHGC3	8.76e-06	331	128	11	int:H2BC5
Interaction	PCDHGB1 interactions	PCDHGC4 PCDHGB5 PCDHGB3 CELSR2 PCDHGB4 PCDHGC3	9.57e-06	77	128	6	int:PCDHGB1
Interaction	ZNF324 interactions	BRPF3 ZNF460 FBL SMARCAD1 NOTCH2	1.06e-05	46	128	5	int:ZNF324
Interaction	HERPUD1 interactions	AMFR UBQLN2 UBQLN1 UBQLN4 HTT	1.18e-05	47	128	5	int:HERPUD1
Interaction	WWTR1 interactions	RB1 DVL2 NAP1L1 PTPN23 JMJD1C ZYX STAT1 MAP3K3 ARID3B AMOT CNOT1 HTT	1.62e-05	422	128	12	int:WWTR1
Interaction	MAP1LC3A interactions	UBQLN2 UBQLN1 UBQLN4 TUBB DVL2 ANKRD62 RAB3GAP1 TRIM55 HTT	2.39e-05	241	128	9	int:MAP1LC3A
Interaction	MDK interactions	UBQLN2 UBQLN1 UBQLN4 CHD9 STAT1 NOTCH2	2.50e-05	91	128	6	int:MDK
Interaction	HGS interactions	UBQLNL DGCR6 UBQLN2 UBQLN1 UBQLN4 TUBB PTPN23 RFX6 USP16 ZYX UBXN11 GOLGA2 HTT	2.91e-05	523	128	13	int:HGS
Interaction	PLAAT3 interactions	UBQLN2 UBQLN1 UBQLN4	3.98e-05	11	128	3	int:PLAAT3
Interaction	ZNF649 interactions	SMARCAD1 TRIM55 NOTCH2	3.98e-05	11	128	3	int:ZNF649
Interaction	LRRC69 interactions	LRRC69 TNFAIP3	4.00e-05	2	128	2	int:LRRC69
Interaction	EDEM1 interactions	AMFR UBQLN2 UBQLN1 CHD9 MSH5 ATM GOLGA2 HTT	4.54e-05	202	128	8	int:EDEM1
Interaction	ZG16 interactions	UBQLN2 UBQLN1 UBQLN4	5.28e-05	12	128	3	int:ZG16
Interaction	USP34 interactions	AMFR UBQLN2 UBQLN1 ZNF460 SEC24A UBQLN4 ATM	6.54e-05	157	128	7	int:USP34
Interaction	RNF43 interactions	SEC24A TUBB DVL2 NAP1L1 MAGT1 JMJD1C CCDC88A AMOT ST13P5 CNOT1 GOLGA2	8.97e-05	427	128	11	int:RNF43
Interaction	VASP interactions	PITRM1 SEC24A DVL2 PTPN23 ZYX STAT2 AMOT FMN2 CEP97	1.11e-04	294	128	9	int:VASP
Interaction	CLPSL2 interactions	UBQLN2 DVL2	1.20e-04	3	128	2	int:CLPSL2
Interaction	SLC5A10 interactions	UBQLN1 UBQLN4	1.20e-04	3	128	2	int:SLC5A10
Interaction	SMIM2 interactions	UBQLN2 UBQLN1	1.20e-04	3	128	2	int:SMIM2
Interaction	DEFB115 interactions	UBQLN2 UBQLN1	1.20e-04	3	128	2	int:DEFB115
Interaction	NBR1 interactions	UBQLN2 TUBB RO60 SMARCAD1 ZYX MAP3K3 AMOT SNRPA ST13P5 HTT	1.59e-04	380	128	10	int:NBR1
Cytoband	5q31	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB4 PCDHGC3	4.00e-08	115	129	7	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 SEC24A PCDHGB4 PCDHGC3	2.22e-06	298	129	8	chr5q31
Cytoband	19q13.1	FBL RYR1 SNRPA	5.11e-04	55	129	3	19q13.1
Cytoband	2q21.3	RAB3GAP1 MAP3K19	8.03e-04	15	129	2	2q21.3
Cytoband	4p15.32	LAP3 CC2D2A	9.16e-04	16	129	2	4p15.32
GeneFamily	Ubiquilin family	UBQLNL UBQLN2 UBQLN1 UBQLN4	2.99e-09	5	91	4	783
GeneFamily	Clustered protocadherins	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB4 PCDHGC3	3.19e-08	64	91	7	20
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	MYO7A NBEA AKAP10	4.10e-04	29	91	3	396
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	MYO7A MYO10 MYO15A	2.04e-03	50	91	3	1293
Coexpression	YOSHIMURA_MAPK8_TARGETS_DN	AMFR DPP4 NRDC RB1 MAGT1 LGALS8 EVI5 AHR ATP12A PCDHGC3 HTT	2.90e-06	379	129	11	M1885
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	DOCK2 ATR NRDC MYO7A IFFO1 U2SURP ASH1L TUBB NAP1L1 RO60 JMJD1C ZYX STAT1 CCDC88A CELF2 AHR AKAP10 PLCB2 ATM TNFAIP3 CNOT1 NOTCH2	3.62e-06	1492	129	22	M40023
Coexpression	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 CHD9 PCDHGB4 PCDHGC3	1.48e-05	222	129	8	M16955
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	STARD13 ATR RB1 MYO10 SEC24A U2SURP CHD9 EVI5 RAB3GAP1 TAF4 SAMD4A	2.02e-05	466	129	11	M13522
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	DPP4 GALNT1 ATR MYO10 TCEAL4 NAP1L1 SMARCAD1 PPWD1 STAT1 LGALS8 CCDC88A CELF2 ATM	2.22e-05	656	129	13	M18979
Coexpression	GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	GALNT1 PPWD1 USP16 STAT1 CELF2 ATM CEP97	3.64e-05	184	129	7	M9005
Coexpression	GAUTAM_EYE_CORNEA_MONOCYTES	CTSA PPWD1 ZYX ARID3B P3H2 ZNF197 ATM CNOT1	4.09e-05	256	129	8	M43601
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	ATR GAS2L3 U2SURP CTSA PPWD1 USP16 LGALS8 SEMA3A TOMM70 CCDC88A PCNX4 PCDHGC3 CNOT1	5.85e-05	721	129	13	M10237
Coexpression	GSE369_IFNG_KO_VS_WT_LIVER_UP	SNX33 MSH5 JMJD1C RAB3GAP1 CEP89 TNFAIP3 CEP97	5.99e-05	199	129	7	M5970
Coexpression	GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_UP	ATP6AP1 NAP1L1 CHD9 PLXND1 CTSA CEP89 PLCB3	6.18e-05	200	129	7	M7153
Coexpression	GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP	RIPK3 RB1 MYO7A EVI5 TOMM70 BRDT PLCB2	6.18e-05	200	129	7	M4021
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	STARD13 GALNT1 ATR RB1 MYO10 SEC24A U2SURP CHD9 EVI5 RAB3GAP1 AKAP10 TAF4 ADGRA3 SAMD4A	8.53e-05	856	129	14	M4500
ToppCell	pdx-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	STARD13 DOCK2 BRPF3 MYO10 LAMA4 SEMA3A MAML3	9.88e-07	182	128	7	7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	MYO10 NAP1L1 ADGRB3 LAMA4 ZYX CYP7B1 MAML3	1.41e-06	192	128	7	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MYO10 NAP1L1 ADGRB3 LAMA4 SEMA3A TNFAIP3 SAMD4A	1.46e-06	193	128	7	cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ASH1L JMJD1C STAT1 STAT2 CELF2 ATM TNFAIP3	1.85e-06	200	128	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	MAK MROH5 RYR1 UBXN11 ZMYND10 ATP12A	3.66e-06	143	128	6	5fb5a4ea93e5cce55d427e3b4a50a979504fad3c
ToppCell	normal_Pleural_Fluid-T/NK_cells-CD4+_Th\|normal_Pleural_Fluid / Location, Cell class and cell subclass	MYO7A DGCR6L RYR1 RANBP17 ZMYND10 TNFAIP3	6.73e-06	159	128	6	ebd840ac2b07e62086ee7b5bb01c21804a0fdc7b
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHGC4 RFX6 RO60 BRDT PCDHGB4 MAML3	7.76e-06	163	128	6	132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCell	facs-MAT-Fat-3m-Myeloid-macrophage\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK2 GAS2L3 PLXND1 AK8 RYR1 CCDC88A	8.04e-06	164	128	6	b81498c3934e0d52bf0329dc745e02966f9d8613
ToppCell	facs\|World / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD9 CTSA MAP3K3 P3H2 PCDHGC3 NOTCH2	1.05e-05	172	128	6	a2d0a64ebf09d219a07d6bbad1056bad6d46b9be
ToppCell	facs-Trachea-24m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DOCK2 PLXND1 ZYX RYR1 AHR PLCB2	1.13e-05	174	128	6	c52aed2ffe9c648e5f23e3459e2d331d6ca214e3
ToppCell	BAL-Severe-cDC_3\|Severe / Compartment, Disease Groups and Clusters	ANKRD31 ADGRB3 P3H2 AMOT AHR ADGRA3	1.24e-05	177	128	6	939487a05311b66edfc3f44a7955fbf25266d6bf
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	STARD13 DOCK2 MYO10 SEMA3A AMOT MAML3	1.32e-05	179	128	6	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	ASH1L CHD9 JMJD1C STAT1 STAT2 TNFAIP3	1.50e-05	183	128	6	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-C\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PCDHGC5 PCDHGC4 PCDHGB3 ZNF460 MSH5 PCDHGC3	1.64e-05	186	128	6	10edc3dd96181b6f7bd07a5ad0862ba9fa6a9cb9
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SNX33 PPWD1 JMJD1C CELF2 AHR ATM	1.69e-05	187	128	6	0099def970fbc828756fbf853eca2ce77b8cd342
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO10 ADGRB3 LAMA4 CYP7B1 ADGRA3 SAMD4A	1.91e-05	191	128	6	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	Leuk-UTI\|World / Disease, Lineage and Cell Type	LRRC69 CTSA LAP3 STAT1 UBXN11 SAMD4A	2.03e-05	193	128	6	26119a0b5d7684022fd16b8b73a0ef5a7d70f3d1
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 DOCK2 PLXND1 RYR1 CELF2 PLCB2	2.09e-05	194	128	6	c95d5c4ad0210ebd672926558cc8331e6396a854
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 DOCK2 GAS2L3 RYR1 CCDC88A CELF2	2.15e-05	195	128	6	247803cf58c6d9c561a52aa34e581188ddad197e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 DOCK2 GAS2L3 RYR1 CELF2 PLCB2	2.15e-05	195	128	6	42bfdff88da1d07828c0ad65d412fb1752f0cee4
ToppCell	COVID-19_Severe-Classical_Monocyte-cMono_4\|COVID-19_Severe / Disease condition and Cell class	LAP3 STAT1 STAT2 AHR TNFAIP3 SAMD4A	2.15e-05	195	128	6	787ea9f38ad8e2a836222ca97f4d927f7e79517d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 DOCK2 PLXND1 RYR1 CELF2 PLCB2	2.21e-05	196	128	6	cbc727b55b6433a701b1a331028a49960fcee6ee
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 GAS2L3 RYR1 CCDC88A CELF2 PLCB2	2.27e-05	197	128	6	d95565652ca318a2298d6918d54ba6367e9560f4
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	USP16 JMJD1C LAP3 STAT1 STAT2 TNFAIP3	2.27e-05	197	128	6	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	USP16 JMJD1C LAP3 STAT1 STAT2 TNFAIP3	2.34e-05	198	128	6	44417089b62056269cac38d3134ff209c05b7007
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	USP16 JMJD1C LAP3 STAT1 STAT2 TNFAIP3	2.34e-05	198	128	6	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 GAS2L3 MYO7A IFFO1 PLXND1 RYR1	2.41e-05	199	128	6	9545ac59c8d75f5747dff86cb511a149dc103b31
ToppCell	control-HLA-DR+_CD83+_Monocyte\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LAP3 STAT1 STAT2 MAP3K3 CCDC88A AHR	2.41e-05	199	128	6	f1b370d2869ad29c9d8ff41fdcc486fffa781ee2
ToppCell	Influenza_Severe-CD4+_T_naive\|World / Disease group and Cell class	ANKRD31 CDH20 BRDT MYO15A ADGRA3	7.10e-05	149	128	5	ce6552063510aa3e0b9d6e5b531eea67410e7056
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO7A STAT2 UBXN11 SIMC1 HTT	8.05e-05	153	128	5	991782d111d66e25b40319d4e6dea40f2c2c0805
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-plasmacytoid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPP4 PCDHGC5 AK8 RYR1 PLCB2	1.02e-04	161	128	5	ed93cb6c133855a5c244821e1a260aae8ab4df9a
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Plasmacytoid_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPP4 PCDHGC5 AK8 RYR1 PLCB2	1.02e-04	161	128	5	0089d7bb305c592392791862a3341fc92af8f3e2
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	DPP4 RIPK3 PCDHGB7 MSH5	1.06e-04	85	128	4	bb9555652e93620d5aeeb71e915b3978a437407d
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--\|Cerebellum / BrainAtlas - Mouse McCarroll V32	DPP4 RIPK3 PCDHGB7 MSH5	1.06e-04	85	128	4	f7935c3206310adafdecb75149c3b06c38e7780c
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	DPP4 RIPK3 PCDHGB7 MSH5	1.06e-04	85	128	4	43f6911b032718d8ba75fb7bba5f9b536a4b3260
ToppCell	normal_Pleural_Fluid-T/NK_cells-CD4+_Th\|T/NK_cells / Location, Cell class and cell subclass	MYO7A RYR1 RANBP17 ZMYND10 TNFAIP3	1.12e-04	164	128	5	334f376350c9cf92611d0f75b2e18a102f4c116a
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRPA1 MYH13 LAMA4 PCDHGB4 PCDHGC3	1.12e-04	164	128	5	a764b79a127c8f360af0b79a1da64658badf0dfa
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_D3\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	DPP4 AK8 P3H2 MAML3 SAMD4A	1.15e-04	165	128	5	a379fa981db51bec01adea7b1e55e133e15ec383
ToppCell	droplet-Heart-nan-18m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOLH1 MSH5 GSTA3 SIMC1 ATM	1.18e-04	166	128	5	9adceb746e67e955fd8b3e0984f4eed44b64a270
ToppCell	lung-Ciliated_Epithelia\|lung / shred on tissue and cell subclass	MAK AK8 ZMYND10 PCNX4 MAP3K19	1.21e-04	167	128	5	26cf1cfa58ee74794449a87eb19cd896e1ec8892
ToppCell	TCGA-Brain\|World / Sample_Type by Project: Shred V9	PCDHGC5 PCDHGC4 ADGRB3 CDH20 FMN2	1.32e-04	170	128	5	f78e360a6a44d599ec0d207cba4704e50aa314f8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 ADGRB3 CCDC88A CELF2 PLCB2	1.36e-04	171	128	5	af1c93eb75f45c042ea475d93db56e4da207e31f
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPP4 RYR1 P3H2 AHR PLCB2	1.39e-04	172	128	5	a5344760b10ecdc0101f78b93b8fc0f8107068c5
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_E\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	PITRM1 MYO10 ARMCX1 PLCB2 MED12	1.43e-04	173	128	5	090dc3c5bd2652a65c2490fc889da858c3af368f
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_E\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PITRM1 MYO10 ARMCX1 PLCB2 MED12	1.47e-04	174	128	5	a79ebb01a5849c314e02594a9c95009dbb03cb8c
ToppCell	356C-Lymphocytic-ILC\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MYO7A CTSA ZYX AHR TNFAIP3	1.59e-04	177	128	5	7ddd7d1854ad42abd630ad0c702105102cec93e7
ToppCell	facs-Lung-EPCAM-3m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR1 CCDC88A PLCB2 TNFAIP3 NOTCH2	1.59e-04	177	128	5	e73e2b6a72630bb56ac2af1cdeedc8f0f828f390
ToppCell	5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP3K3 SEMA3A PCDHGB4 SGCE PCDHGC3	1.59e-04	177	128	5	3a85aa2bf3f2fdbea57d22d68e022cb3f6c2eb65
ToppCell	facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ATR PTPN23 PCNX4 CC2D2A PLCB2	1.64e-04	178	128	5	89f0537459a321ded956bf70ad56fefc0854f8b0
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NAP1L1 ZMYND10 CC2D2A CEP97 MAP3K19	1.68e-04	179	128	5	d15182c668d7c37be8214cad9f1fe35d1409c9a1
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NAP1L1 ZMYND10 CC2D2A CEP97 MAP3K19	1.68e-04	179	128	5	e22a275a7c0ed19113c833a75d6c49fcc19aa13a
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Dendritic_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATR PTPN23 PCNX4 CC2D2A PLCB2	1.72e-04	180	128	5	710526abedc8e0f9ba19ad69220df4c9468ada8f
ToppCell	356C-Lymphocytic-ILC-ILC-1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MYO7A CTSA ZYX AHR TNFAIP3	1.72e-04	180	128	5	cedbe692c5257fb6f9a552e2f197163626ac17d9
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	ASH1L JMJD1C CELF2 ATM TNFAIP3	1.77e-04	181	128	5	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	B_cells-ISG-high_B_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	AMFR STAT1 STAT2 ATP12A SAMD4A	1.86e-04	183	128	5	dc2b00e920efa1dcc2a6265cd1024e3249c9974f
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-C\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PCDHGC5 PCDHGB3 ZNF460 PCDHGB4 PCDHGC3	1.91e-04	184	128	5	629cfed10e1112cf30f6a828ce9efbbc6b207789
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ANKRD31 ADGRB3 P3H2 AMOT AHR	1.91e-04	184	128	5	1c56378b3888c46258d446b47de4d6282fe74b0d
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ANKRD31 ADGRB3 P3H2 AMOT AHR	1.91e-04	184	128	5	a45980306c4e697a2703bed72a7b48fb23d942f4
ToppCell	IPF-Epithelial-ATII\|IPF / Disease state, Lineage and Cell class	DPP4 MYL1 RANBP17 P3H2 AHR	1.96e-04	185	128	5	563b4e6d92bb5d77a3829556116a8e99aebac615
ToppCell	IPF-Epithelial-ATII\|World / Disease state, Lineage and Cell class	DPP4 MYL1 RANBP17 P3H2 AHR	2.01e-04	186	128	5	6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYH13 RFX6 JMJD1C CCDC88A AHR	2.01e-04	186	128	5	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	IPF-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	DPP4 MYL1 CELF2 P3H2 AHR	2.11e-04	188	128	5	5f5fad2773e421760e67dbace23fd1f847a2e1e0
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCDHGB5 PPWD1 CELF2 AKAP10 NOTCH2	2.11e-04	188	128	5	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCDHGB5 PPWD1 CELF2 AKAP10 NOTCH2	2.11e-04	188	128	5	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCDHGB5 PPWD1 CELF2 AKAP10 NOTCH2	2.11e-04	188	128	5	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	AK8 GSTA3 ZMYND10 FMN2 MAP3K19	2.16e-04	189	128	5	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 GAS2L3 RYR1 CELF2 PLCB2	2.21e-04	190	128	5	788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FOLH1 MYO10 CDH20 NFATC4 NOTCH2	2.21e-04	190	128	5	2de8e4cfeee350a9a76af749d6ce58d948c129b8
ToppCell	ASK454-Epithelial-Ciliated\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	DGCR6 ZNF460 ARID3B UBXN11 AMOT	2.21e-04	190	128	5	5cea6480f08253d7adf484e511d3fdfa96641268
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 GAS2L3 RYR1 CELF2 PLCB2	2.27e-04	191	128	5	baa70781633a3fe5bf987f9d8dff3884f5167e7f
ToppCell	droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DGCR6 PLXND1 CELF2 BRDT CEP97	2.27e-04	191	128	5	4bd9db45e7b5c0d04368e08c8199d390744aa317
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	ASH1L JMJD1C CELF2 ATM TNFAIP3	2.32e-04	192	128	5	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DPP4 MYL1 RANBP17 CELSR2 P3H2	2.32e-04	192	128	5	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	Control-Myeloid-Monocyte-derived_macrophages\|Control / group, cell type (main and fine annotations)	DOCK2 GAS2L3 CTSA RYR1 CCDC88A	2.38e-04	193	128	5	a6b3bd01e585e2e3fbe9bf693a2e385773123f8e
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)\|Adult / Lineage, Cell type, age group and donor	STARD13 DOCK2 MYO7A PLXND1 RYR1	2.38e-04	193	128	5	31c0978ba78c9516d498aec0798902e57555e557
ToppCell	Mild/Remission-B_activate-7\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	JMJD1C LAP3 STAT1 STAT2 SAMD4A	2.44e-04	194	128	5	01c97543972159a9468272da06e7e611e2c21fae
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 CELF2 PLCB2 ATM TNFAIP3	2.44e-04	194	128	5	4dfc890bacf133cfb6ec7c8b73f084f2491cf78e
ToppCell	390C-Lymphocytic-CD4_T-cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	DPP4 NAP1L1 CTSA AHR TNFAIP3	2.44e-04	194	128	5	76c4c3ba5f1bcc39d397c90db3513f5bea632b1b
ToppCell	(6)_Endothelial_cells-(6)_Endothelial-F_(Lymphatics)\|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	LAMA4 PKHD1L1 SEMA3A P3H2 SGCE	2.44e-04	194	128	5	9441202d6fa2ffbef9277d48ae9bc98876c26ec5
ToppCell	COVID-19_Severe-Classical_Monocyte-cMono_4\|Classical_Monocyte / Disease condition and Cell class	LAP3 STAT1 STAT2 TNFAIP3 SAMD4A	2.50e-04	195	128	5	1992a1673b7213e25f3c76ac77da35c57daceddd
ToppCell	IPF-Endothelial-Lymphatic\|Endothelial / Disease state, Lineage and Cell class	LAMA4 PKHD1L1 SEMA3A P3H2 SGCE	2.50e-04	195	128	5	de88e9d22044b4b3e29676ad02b3e9299cc920ad
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	UBQLNL NAP1L1 CELF2 AHR PLCB2	2.50e-04	195	128	5	a2fe352682f548001ca2ee056e7a54af10134453
ToppCell	TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type\|TCGA-Adrenal / Sample_Type by Project: Shred V9	GAS2L3 CTSA GSTA3 P3H2 NR1H4	2.50e-04	195	128	5	c3280bb6219e2eff5e24ef45aa2d76479a562122
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-C\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PCDHGC5 GAS2L3 ZNF460 MSH5 PCDHGC3	2.50e-04	195	128	5	bda3ca3d26afd06c226bc6fd1d8fd85a0e4fb52b
ToppCell	control-Lymphoid-Treg\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DPP4 PLXND1 CELF2 AKAP10 TNFAIP3	2.50e-04	195	128	5	66959ae839eb60a573da06bdd227090ebb5bb9ed
ToppCell	Control-Classical_Monocyte-cMono_2\|Control / Disease condition and Cell class	CTSA JMJD1C MAP3K3 AHR TNFAIP3	2.50e-04	195	128	5	0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9
ToppCell	B_cells-ISG-high_B_cells\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	AMFR LAP3 STAT1 STAT2 SAMD4A	2.50e-04	195	128	5	b64d9e1a8834401b4dc501566546647754ae21fc
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 ASH1L NBEA RFX6 FMN2	2.50e-04	195	128	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	PCW_05-06-Mesenchymal\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	NAP1L1 ADGRB3 LAMA4 SEMA3A NOTCH2	2.56e-04	196	128	5	dca52c57ba35d9395cdbca8b881f12ece721b10f
ToppCell	ILEUM-non-inflamed-(9)_Enteric_neurons\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	STARD13 GAS2L3 ADGRB3 P3H2 SGCE	2.56e-04	196	128	5	998aa523555ed6bc9c1b5cacbf7ba77c7b218e6b
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MYO10 NAP1L1 ADGRB3 LAMA4 SEMA3A	2.56e-04	196	128	5	22538376a95fe3afe8639a216a5497087aa94110
ToppCell	Children_(3_yrs)-Immune-monocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DOCK2 MAP3K3 CCDC88A PLCB2 MAML3	2.56e-04	196	128	5	cacd69be72e6167814f7adea7c5fa114f3103bbb
ToppCell	ILEUM-non-inflamed-(9)_Neuro_cell\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	STARD13 GAS2L3 ADGRB3 P3H2 SGCE	2.56e-04	196	128	5	2b08cd6730119d5dea0152709ab8de580b66cd3c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 RYR1 CCDC88A CELF2 MAML3	2.62e-04	197	128	5	8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG\|World / Primary Cells by Cluster	MYO10 NFATC4 P3H2 NOTCH2 SAMD4A	2.62e-04	197	128	5	61749ccafeb938c310cff1de5ff924a1c794325a
ToppCell	BL\|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DOCK2 NRDC STAT1 CELF2 TNFAIP3	2.62e-04	197	128	5	1acf0191fa0a25cd20bfd9ea7bf727a1555986a1
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG-25\|World / Primary Cells by Cluster	MYO10 NFATC4 P3H2 NOTCH2 SAMD4A	2.62e-04	197	128	5	9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 CCDC88A CELF2 PLCB2 MAML3	2.62e-04	197	128	5	1eb9ff8467118b943b5d443cb996168e1e1206b5
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 RYR1 CCDC88A CELF2 PLCB2	2.68e-04	198	128	5	96883ad8e189a46ed5b7eaafc0543e53682d26ed
ToppCell	Control_saline-Epithelial_airway\|Control_saline / Treatment groups by lineage, cell group, cell type	ARHGEF38 AK8 GSTA3 ZMYND10 MAP3K19	2.68e-04	198	128	5	e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
Computational	Neighborhood of LTK	AMFR DGCR6 PLCB2 ATM HTT	3.09e-05	46	86	5	GCM_LTK
Drug	carmustine; Up 200; 100uM; MCF7; HT_HG-U133A	ATR SEC24A U2SURP PPWD1 JMJD1C EVI5 RAB3GAP1 PCNX4 ATM CEP97 SAMD4A	1.09e-08	192	127	11	6914_UP
Drug	CID9959010	PCDHGC5 PCDHGC4 PCDHGB7 RYR1 PCDHGC3	2.47e-06	39	127	5	CID009959010
Drug	Isocyanates	TRPA1 ATR RB1 ATM	2.66e-06	18	127	4	ctd:D017953
Drug	monensin; Up 200; 10.9uM; MCF7; HT_HG-U133A_EA	AMFR DVL2 ARMCX1 LGALS8 CELSR2 PCNX4 ATM GOLGA2	5.16e-06	170	127	8	1105_UP
Drug	Methoxsalen	ATR RB1 AHR ATM NR1H4	7.05e-06	48	127	5	ctd:D008730
Drug	8-bromoguanine	RB1 SMARCAD1 STAT2 BRDT AHR	1.16e-05	53	127	5	CID000076473
Drug	Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; PC3; HT_HG-U133A	RB1 LAMA4 PLXND1 STAT2 ZMYND10 NOS1 NOTCH2 SAMD4A	1.46e-05	196	127	8	5112_UP
Drug	Tadjakonine [11087-94-8]; Down 200; 7.4uM; HL60; HT_HG-U133A	STARD13 RB1 RO60 GSTA3 RANBP17 CELSR2 PLCB3 NOS1	1.63e-05	199	127	8	2165_DN
Drug	AC1NFC6P	PCDHGC5 PCDHGC4 PCDHGB7 MYO10 PLCB2 PLCB3 PCDHGC3	1.98e-05	148	127	7	CID000004587
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB4 PCDHGC3	2.59e-08	71	128	7	EFO_0007878, EFO_0007979
Disease	amyotrophic lateral sclerosis type 15 (implicated_via_orthology)	UBQLN2 UBQLN1 UBQLN4	7.97e-08	3	128	3	DOID:0060206 (implicated_via_orthology)
Disease	mean platelet volume	PCDHGC5 PCDHGC4 NRDC PCDHGB7 PCDHGB5 PCDHGB3 FOLH1 U2SURP TUBB CHD9 PLXND1 JMJD1C CELF2 PCDHGB4 AKAP10 PCDHGC3 HTT	2.11e-06	1020	128	17	EFO_0004584
Disease	neurodegenerative disease (implicated_via_orthology)	UBQLN2 UBQLN1 NRDC UBQLN4 DVL2 CEP89 HTT	3.44e-06	145	128	7	DOID:1289 (implicated_via_orthology)
Disease	frontotemporal dementia (implicated_via_orthology)	UBQLN2 UBQLN1 UBQLN4	1.70e-05	12	128	3	DOID:9255 (implicated_via_orthology)
Disease	ataxia telangiectasia (implicated_via_orthology)	ATR ATM	1.87e-05	2	128	2	DOID:12704 (implicated_via_orthology)
Disease	Neoplasm of uncertain or unknown behavior of bladder	RB1 ATM NOTCH2	3.49e-05	15	128	3	C0496930
Disease	Benign neoplasm of bladder	RB1 ATM NOTCH2	3.49e-05	15	128	3	C0154017
Disease	Carcinoma in situ of bladder	RB1 ATM NOTCH2	3.49e-05	15	128	3	C0154091
Disease	Carcinoma of bladder	RB1 ATM NOTCH2	6.20e-05	18	128	3	C0699885
Disease	Prostatic Neoplasms	ATR RB1 FOLH1 ASH1L RFX6 SMARCAD1 CELF2 AHR CYP7B1 ATM MED12	8.06e-05	616	128	11	C0033578
Disease	Malignant neoplasm of prostate	ATR RB1 FOLH1 ASH1L RFX6 SMARCAD1 CELF2 AHR CYP7B1 ATM MED12	8.06e-05	616	128	11	C0376358
Disease	mental development measurement	PCDHGB5 PCDHGB3 PCDHGB4	1.71e-04	25	128	3	EFO_0008230
Disease	reticulocyte count	DGCR6 ATR U2SURP ASH1L TUBB LAMA4 JMJD1C DGCR6L STAT1 CDH20 PCDHGB4 AKAP10 PLCB3 MED12	1.83e-04	1045	128	14	EFO_0007986
Disease	proline measurement, amino acid measurement	DGCR6 DGCR6L	1.85e-04	5	128	2	EFO_0005134, EFO_0009773
Disease	amyotrophic lateral sclerosis (implicated_via_orthology)	UBQLN2 UBQLN1 UBQLN4	2.97e-04	30	128	3	DOID:332 (implicated_via_orthology)
Disease	obesity (implicated_via_orthology)	PLXND1 STAT1 PLCB2 PLCB3 MED12 NOTCH2	3.62e-04	215	128	6	DOID:9970 (implicated_via_orthology)
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	ANKRD31 AMFR JMJD1C CELSR2 PLCB3	4.22e-04	144	128	5	EFO_0004611, EFO_0020943
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	ANKRD31 JMJD1C CELSR2 PLCB3 HTT	5.08e-04	150	128	5	EFO_0004611, EFO_0020947
Disease	lymphocyte count	DOCK2 PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 RB1 PCDHGB3 TCEAL4 PLXND1 JMJD1C ZMYND10 PCDHGB4 ATM PCDHGC3 NOTCH2 HTT	6.13e-04	1464	128	16	EFO_0004587
Disease	Lymphoma	ATM TNFAIP3 NOTCH2	7.01e-04	40	128	3	C0024299
Disease	Malignant neoplasm of breast	AMFR RB1 FBL ARHGEF38 STAT1 SEMA3A CDH20 P3H2 AHR ATM MED12 NOTCH2 ZNF541	8.13e-04	1074	128	13	C0006142
Disease	stromal cell-derived factor 1 alpha measurement	CDH20 PCDHGB4 ADGRA3	8.67e-04	43	128	3	EFO_0008293
Disease	nasopharynx carcinoma (is_marker_for)	ATR ATM TNFAIP3	8.67e-04	43	128	3	DOID:9261 (is_marker_for)
Disease	fibrinogen measurement, tissue plasminogen activator measurement	CHD9 PLXND1 JMJD1C	9.90e-04	45	128	3	EFO_0004623, EFO_0004791
Disease	cholesterol to total lipids in large VLDL percentage	ANKRD31 JMJD1C CELSR2	9.90e-04	45	128	3	EFO_0022236
Disease	1-methylxanthine measurement	AHR CYP7B1	1.00e-03	11	128	2	EFO_0021174
Disease	Congenital myopathy (disorder)	MYL1 RYR1	1.20e-03	12	128	2	C0270960
Disease	cholesteryl esters to total lipids in small VLDL percentage	ANKRD31 JMJD1C CELSR2	1.27e-03	49	128	3	EFO_0022256
Disease	free cholesterol in large LDL measurement	ANKRD31 JMJD1C CELSR2	1.43e-03	51	128	3	EFO_0022176
Disease	cholesterol to total lipids in small VLDL percentage	ANKRD31 JMJD1C CELSR2	1.43e-03	51	128	3	EFO_0022242
Disease	triglycerides to total lipids in very large VLDL percentage	ANKRD31 JMJD1C CELSR2	1.59e-03	53	128	3	EFO_0022340
Disease	Depressive disorder	DPP4 FOLH1 SGCE NOS1 MED12 HTT	1.68e-03	289	128	6	C0011581
Disease	cholesteryl esters to total lipids in large VLDL percentage	ANKRD31 JMJD1C CELSR2	1.87e-03	56	128	3	EFO_0022250
Disease	Lymphoma, Follicular, Grade 2	ATP6AP1 TNFAIP3	1.89e-03	15	128	2	C1956132
Disease	Lymphoma, Follicular, Grade 3	ATP6AP1 TNFAIP3	1.89e-03	15	128	2	C1956131
Disease	Lymphoma, Follicular, Grade 1	ATP6AP1 TNFAIP3	1.89e-03	15	128	2	C1956130
Disease	Lymphoma, Large-Cell, Follicular	ATP6AP1 TNFAIP3	1.89e-03	15	128	2	C0079745
Disease	Lymphoma, Small Cleaved-Cell, Follicular	ATP6AP1 TNFAIP3	1.89e-03	15	128	2	C0079765
Disease	Lymphoma, Mixed-Cell, Follicular	ATP6AP1 TNFAIP3	1.89e-03	15	128	2	C0079758
Disease	superior parietal cortex volume measurement	GALNT1 ADGRB3	1.89e-03	15	128	2	EFO_0010330
Disease	free cholesterol to total lipids in medium VLDL percentage	ANKRD31 JMJD1C CELSR2	1.97e-03	57	128	3	EFO_0022284
Disease	triglycerides to total lipids in small VLDL percentage	ANKRD31 JMJD1C CELSR2	2.07e-03	58	128	3	EFO_0022338
Disease	cholesterol in IDL measurement	ANKRD31 JMJD1C CELSR2	2.07e-03	58	128	3	EFO_0021899
Disease	reticulocyte measurement	DGCR6 ATR U2SURP ASH1L TUBB JMJD1C DGCR6L STAT1 CDH20 PCDHGB4 PLCB3 MED12	2.14e-03	1053	128	12	EFO_0010700
Disease	DiGeorge Syndrome	DGCR6 JMJD1C	2.15e-03	16	128	2	C0012236
Disease	CONOTRUNCAL ANOMALY FACE SYNDROME	DGCR6 JMJD1C	2.15e-03	16	128	2	C0795907
Disease	migraine disorder, fasting blood insulin measurement	ADGRB3 AKAP10	2.15e-03	16	128	2	EFO_0004466, MONDO_0005277
Disease	Shprintzen syndrome	DGCR6 JMJD1C	2.15e-03	16	128	2	C0220704
Disease	triglycerides to total lipids in small LDL percentage	JMJD1C CELSR2 PLCB3	2.17e-03	59	128	3	EFO_0022337
Disease	free cholesterol to total lipids in very large VLDL percentage	ANKRD31 JMJD1C CELSR2	2.17e-03	59	128	3	EFO_0022289
Disease	total lipids in IDL	ANKRD31 JMJD1C CELSR2	2.28e-03	60	128	3	EFO_0022161
Disease	unipolar depression	AMFR MAK MYH13 NRDC MYO10 ASH1L AK8 TRIM55 CYP7B1 NOS1 MAML3 MED12 HTT	2.28e-03	1206	128	13	EFO_0003761
Disease	Inflammation	TRPA1 AHR TNFAIP3 NR1H4	2.31e-03	127	128	4	C0021368
Disease	free cholesterol in IDL measurement	ANKRD31 JMJD1C CELSR2	2.39e-03	61	128	3	EFO_0022181
Disease	psoriasis vulgaris	STAT2 P3H2 TNFAIP3	2.39e-03	61	128	3	EFO_1001494
Disease	Benign neoplasm of stomach	ATR ATM	2.43e-03	17	128	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	ATR ATM	2.43e-03	17	128	2	C0496905
Disease	Carcinoma in situ of stomach	ATR ATM	2.43e-03	17	128	2	C0154060
Disease	triglycerides to total lipids in medium VLDL percentage	ANKRD31 JMJD1C CELSR2	2.62e-03	63	128	3	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	ANKRD31 JMJD1C CELSR2	2.62e-03	63	128	3	EFO_0022239
Disease	non-alcoholic steatohepatitis (is_marker_for)	RIPK3 NR1H4	2.73e-03	18	128	2	DOID:0080547 (is_marker_for)
Disease	Adrenocortical carcinoma	RB1 MED12	2.73e-03	18	128	2	C0206686
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	ANKRD31 JMJD1C CELSR2 PLCB3 HTT	2.88e-03	222	128	5	EFO_0008317, EFO_0020943
Disease	portal hypertension (implicated_via_orthology)	NOS1 NR1H4	3.04e-03	19	128	2	DOID:10762 (implicated_via_orthology)
Disease	Cannabis use, age at onset	CDH20 PCDHGB4	3.04e-03	19	128	2	EFO_0004847, EFO_0007585
Disease	hydrocephalus (implicated_via_orthology)	AK8 CELSR2	3.04e-03	19	128	2	DOID:10908 (implicated_via_orthology)
Disease	caffeine metabolite measurement	ARID3B AHR	3.04e-03	19	128	2	EFO_0007872
Disease	leukemia (implicated_via_orthology)	ASH1L ATM	3.04e-03	19	128	2	DOID:1240 (implicated_via_orthology)
Disease	free cholesterol in large VLDL measurement	ANKRD31 JMJD1C CELSR2	3.25e-03	68	128	3	EFO_0022265
Disease	Bladder Neoplasm	AMFR RB1 ATM NOTCH2	3.29e-03	140	128	4	C0005695
Disease	sucrose liking measurement	CDH20 PCDHGB4	3.37e-03	20	128	2	EFO_0010157
Disease	Lymphoma, Follicular	ATP6AP1 TNFAIP3	3.37e-03	20	128	2	C0024301
Disease	Malignant neoplasm of urinary bladder	AMFR RB1 ATM NOTCH2	3.37e-03	141	128	4	C0005684
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	ANKRD31 CELSR2 MAML3	3.39e-03	69	128	3	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	testosterone measurement	STARD13 UBQLN2 NRDC UBQLN4 JMJD1C SEMA3A EVI5 P3H2 TAF4 ATP12A MYO15A MED12 NR1H4	3.67e-03	1275	128	13	EFO_0004908
Disease	Infiltrating duct carcinoma of female breast	MAK ATR	3.71e-03	21	128	2	C3165106
Disease	Stomach Carcinoma	ATR ATM	3.71e-03	21	128	2	C0699791
Disease	Sarcoma	RB1 MAML3	3.71e-03	21	128	2	C1261473
Disease	Liver diseases	AHR CYP7B1 NR1H4	3.82e-03	72	128	3	C0023895
Disease	Liver Dysfunction	AHR CYP7B1 NR1H4	3.82e-03	72	128	3	C0086565
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	ANKRD31 JMJD1C CELSR2 PLCB3 HTT	3.95e-03	239	128	5	EFO_0008317, EFO_0020945
Disease	progranulin measurement	UBQLN1 CELSR2	4.07e-03	22	128	2	EFO_0004625
Disease	e-selectin measurement	EVI5 CELSR2	4.07e-03	22	128	2	EFO_0004575
Disease	Granulomatous Slack Skin	ATM TNFAIP3	4.07e-03	22	128	2	C0376407
Disease	esophagus squamous cell carcinoma (is_marker_for)	DPP4 ATM TNFAIP3	4.13e-03	74	128	3	DOID:3748 (is_marker_for)
Disease	free cholesterol to total lipids in small VLDL percentage	ANKRD31 JMJD1C CELSR2	4.29e-03	75	128	3	EFO_0022287

Protein segments in the cluster

Peptide	Gene	Start	Entry
LNPSSLLAAMMQQDE	AHR	451	P35869
APLQMDAREKQGQQM	ARID3B	21	Q8IVW6
IMEKQLSPRMQNNEE	AMOT	91	Q4VCS5
SLLQRMVQNEDQEPM	ASH1L	1716	Q9NR48
DQDILQMFMPFGNVI	CELF2	436	O95319
FMQKLSQMPQEEQVV	BRDT	126	Q58F21
MDQFNMNLEQHLAPQ	ADGRB3	1356	O60242
MIVSDIMQQAQYDQP	AKAP10	641	O43572
MDPQLERQMETTQNL	DNM1P46	46	Q6ZS02
MFNQMPLNLTNAVAT	ADGRA3	426	Q8IWK6
QDAMPLALQSVMDLQ	ARHGEF38	371	Q9NXL2
NVLMDENTMLNSELQ	ANKRD62	626	A6NC57
KVQQAAMELELMPFN	BRPF3	581	Q9ULD4
QSLQEQLNGVMPIAM	CELSR2	2886	Q9HCU4
VTTNPQELMLQMNLL	DGCR6	166	Q14129
IEPGDMLLQVNDMNF	DVL2	311	O14641
VMVAFQDVAQNPANM	ST13P5	331	Q8NFI4
VMVAFQDVAQNPANM	ST13	331	P50502
MMILNSASDQPSENL	RB1	386	P06400
FMQQNPDVLQQMMSV	RANBP17	971	Q9H2T7
VVPQSMQDLLGMNND	RAB3GAP1	96	Q15042
NTDNMPLTGQMELSQ	RFX6	621	Q8HWS3
QMMQNPQILAALQER	NAP1L1	41	P55209
NEVLDQFMDSMQLDP	PTPN23	391	Q9H3S7
MVMQFQGLENPIQIS	NR1H4	1	Q96RI1
NNQFDTEMLQAMILA	PCDHGB4	831	Q9UN71
PNNQFDTEMLQAMIL	PCDHGB7	836	Q9Y5F8
RFVMNQLAENNPFLM	LRRC69	256	Q6ZNQ3
QNLARQLMETPANEM	LAP3	196	P28838
NSSAQNFRMQDPALM	ANKRD31	426	Q8N7Z5
AMMPQQDGQVAQTIL	NOTCH2	2356	Q04721
DVFQMLNMNSAPTFI	MAGT1	126	Q9H0U3
PIQEMMTFVQFANDE	nan	271	A8MVJ9
DMSPAEQLKQMAAQQ	MAML3	461	Q96JK9
MMLSLNNLQNIIYNP	LGALS8	1	O00214
FVTMPSQNMLEFNLA	MYO15A	2826	Q9UKN7
NIMSSFNKMIPQQAL	ATP12A	171	P54707
QNVDPSMVQMTFLDD	JMJD1C	231	Q15652
QDFDKSNPIVLRMMN	FOLH1	651	Q04609
QETLQQLIMMSLPNV	CCDC88A	91	Q3V6T2
NDGSLMFQQVPMVEI	GSTA3	46	Q16772
LMQNMLEQLLIHQPE	AK8	26	Q96MA6
FVVNMPALEHMNQIL	PCNX4	231	Q63HM2
QIQDMTPLSEQEMNA	PLXND1	1841	Q9Y4D7
PNNQFDTEMLQAMIL	PCDHGC5	851	Q9Y5F6
GLALLQMNQAELMQL	EVI5	356	O60447
MQQENMKPQEQLTLE	FBL	286	P22087
MQKMPDQFDQAVVLN	MYO10	641	Q9HD67
MIKQTPNNEMNSLLE	MED12	1366	Q93074
DNSALDKMLQNVQMP	DPP4	496	P27487
EQFLPMMQAISNNKD	MYL1	111	P05976
NLQLVPTMQLFMQLA	MUC5AC	546	P98088
NNQFDTEMLQAMILA	PCDHGB5	831	Q9Y5G0
VANPEHMEMQQNIEN	P3H2	176	Q8IVL5
PNNQFDTEMLQAMIL	PCDHGB3	836	Q9Y5G1
PNNQFDTEMLQAMIL	PCDHGC3	841	Q9UN70
NNQFDTEMLQAMILA	PCDHGC4	846	Q9Y5F7
DNPTAQQIMQLLREM	GOLGA2	956	Q08379
MEDHMFGVQQIQPNV	NOS1	1	P29475
QRNCEDMIQMFQVPS	IFFO1	346	Q0D2I5
TLAVLVMQDPSMNLQ	CTSA	186	P10619
PNQQFLERDQMSMEG	PLCB3	281	Q01970
INQFNLMASEMIALN	GALNT1	81	Q10472
DQMVDIMRASQDNPQ	ATM	1626	Q13315
SAPLQLMSMQNLEFI	ATR	191	Q13535
GQTNVPNLVNTMMEL	CHD9	1126	Q3L8U1
AANLQSSMAQLPMEE	HTT	2021	P42858
NQNIMENRLLMQDPE	CC2D2A	326	Q9P2K1
REDFQMQLMTQFPNA	DOCK2	1371	Q92608
MMINQYQSDETLPIN	DOCK2	1511	Q92608
NITVLAMEMNNPSQV	CDH20	461	Q9HBT6
ENMDLNNMNQSLTLE	CEP89	246	Q96ST8
ELEQLSIMNNPCVMA	CEP97	196	Q8IW35
EMNPLSAVNMFQKQN	GAS2L3	316	Q86XJ1
VTTNPQELMLQMNLL	DGCR6L	166	Q9BY27
PNASNEAIQLMTEML	MAK	251	P20794
SMMQNLKQVFEPQLL	CYP7B1	156	O75881
MQPFKENMEQFIIQA	FMN2	1606	Q9NZ56
LIVQMGPQEENLMIQ	RYR1	2166	P21817
LMQNAQLSMQDNIGE	KIFBP	321	Q96EK5
MNLAQTPEQSMKQNE	MAP3K19	786	Q56UN5
ALNSIMNDLVALQMN	MAP3K3	6	Q99759
MEVQQATAPMANNLT	LAMA4	746	Q16363
LDFMLQSLIMQNPTA	MROH5	566	Q6ZUA9
IQFFLLPQNLDMAQM	MSH5	291	O43196
LMIPQQALAQMQAQA	TAF4	466	O00268
EENQMTPMNLAVCLA	STARD13	801	Q9Y3M8
QDNFQEDPIQMSMII	STAT1	91	P42224
MAQWEMLQNLDSPFQ	STAT2	1	P52630
QNNLLELMSLLNFVM	SMARCAD1	661	Q9H4L7
VLEMTLLPENNMAAN	NFATC4	506	Q14934
RDESPMKANFLQNMI	SEC24A	1056	O95486
FLPQSPLMFKDQMQQ	NBEA	2571	Q8NFP9
DQMQQDVIMVLKFPS	NBEA	2581	Q8NFP9
TELQQMRQQLPDMEF	PPWD1	326	Q96BP3
NLPDMMQLWSEIFNN	PITRM1	676	Q5JRX3
MFAEQPKNDLFQMLD	SNX33	456	Q8WV41
QNDVQNRDMPMDISA	SIMC1	356	Q8NDZ2
FMQLINHPNLNTMDE	SEMA3A	706	Q14563
MEESVNQMQPLNEKQ	RO60	1	P10155
YDSTNMPLMQTQQNL	SGCE	406	O43556
LYLGNINPQMNEEML	U2SURP	276	O15042
QLNAMAHQIQEMFPQ	AMFR	456	Q9UKV5
QIMKLIINFTENPAM	ARMCX1	346	Q9P291
SPQQREMMDQAAAQL	CNOT1	1481	A5YKK6
MASNQGKMENEEQPQ	TCEAL4	11	Q96EI5
CSMMIQNQVSPEDAL	ZNF460	136	Q14592
NQLMALMLLTAQPQE	ZNF197	201	O14709
IQFMDEPEMAVFLQN	TRIM55	266	Q9BYV6
NLRPEFMQMQQIKEL	TRPA1	391	O75762
PLTLAMSQFLNEMQE	USP16	256	Q9Y5T5
MAEQVLPQALYLSNM	TNFAIP3	1	P21580
PKTDEVFQMVENNMN	RIPK3	281	Q9Y572
LQSQMQRQLLSNPEM	UBQLN1	171	Q9UMX0
FLQQMQNPDTLSAMS	UBQLN1	441	Q9UMX0
VPELTQQVFDAKNMM	TUBB	286	P07437
DDRMLTLNNDQVFPM	MYH13	66	Q9UKX3
ENMCENMQLYPLQDI	NRDC	566	O43847
MYMQQQQPLLSTQDF	TOMM70	376	O94826
SPWQMMLQDFQIQAF	ATP6AP1	391	Q15904
TQNPDMFNIIDMRNG	PKHD1L1	2931	Q86WI1
NLAMIQEIMQIQQPS	UBQLNL	231	Q8IYU4
DINDQMLNSMQDPFG	UBQLNL	276	Q8IYU4
AQIMLFTSMPQLSEQ	UBQLNL	441	Q8IYU4
QMVALNFQTMDLPMQ	PLCB2	626	Q00722
NFQTMDLPMQQNMAV	PLCB2	631	Q00722
DLPMQQNMAVFEFNG	PLCB2	636	Q00722
MNEMDIRNFQPQVSL	ZNF33A	776	Q06730
QLTQQLMQDMEHPQR	ZYX	361	Q15942
SNPMQELQKQAELME	ZMYND10	166	O75800
ELQSQMQQQLMASPE	UBQLN2	166	Q9UHD9
MQSLSQNPDLAAQMM	UBQLN2	396	Q9UHD9
QQLMERNPEISHMLN	UBQLN4	226	Q9NRR5
QTLAQNPDFAAQMMV	UBQLN4	411	Q9NRR5
NPDFAAQMMVNVPLF	UBQLN4	416	Q9NRR5
SPQNMLMFQQPEFQL	SAMD4A	671	Q9UPU9
PEETNELMLSMLFNQ	SNRPA	216	P09012
GEQAFLLMMQPDNTI	UBXN11	406	Q5T124
QEPLVSHEQMQVFQM	ZNF541	546	Q9H0D2
DNQDALDMIANKPMN	MYO7A	491	Q13402